aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Beacon Biosignals, founded with the mission to enhance human health through AI-powered analysis of brain activity, focuses on improving the speed and accuracy of EEG reports. The company offers a neurobiomarker platform designed to accelerate clinical trials and enable new treatments for neurological and psychiatric diseases. Their services include quantitative assessment of treatment efficacy and dose selection, leveraging advanced AI to streamline clinical endpoints.
Notable figures affiliated with Beacon Biosignals include experts in neurology and AI, though specific names are not provided. The company has achieved significant milestones in delivering rapid and precise EEG reports, eliminating the need for traditional adjudication processes. Beacon Biosignals has made a substantial impact on the precision medicine landscape, particularly in the realm of neurological and psychiatric conditions, by enabling more efficient and effective clinical trials.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
EEG Reports
Technology
AI
Tags
Biotech
Model Types
Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Beacon Biosignals founded?
Beacon Biosignals was founded in 2019.
Where is Beacon Biosignals’s headquarters located?
Beacon Biosignals’s headquarters is located in Boston, MA, US.
When was Beacon Biosignals’s last funding round?
Beacon Biosignals’s most recent funding round was for $27M (USD) in November 2021.
How many employees does Beacon Biosignals have?
Beacon Biosignals has 56 employees as of Feb 5, 2024.
How much has Beacon Biosignals raised to-date?
As of July 05, 2023, Beacon Biosignals has raised a total of $30M (USD) since Nov 8, 2021.
Add Comparison
Total Raised to Date
$30M
USD
Last Update Nov 8, 2021
Last Deal Details
$27M
USD
Nov 8, 2021
Series A
Total Employees Over Time
56
As of Feb 2024
Beacon Biosignals Address
Boston,
Massachusetts
02114
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts